EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Phenobarbital Loading Dose in Reducing Cumulative Benzodiazepine Utilization in Patients With Alcohol Withdrawal Syndrome

Taylor Le iD, Sabrina Staas, Robyn Firmin, Jennifer Dwyer, Thomas Bushell, Chaitanya Mishra, Thomas Smoot

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280251383490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Taylor Le und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Frederick Health Hospital, Frederick, MD, USA. Hauptthemen laut MEDLINE: Phenobarbital, Benzodiazepines, Substance Withdrawal Syndrome, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a lack of information regarding the combination therapy of phenobarbital (PB) and benzodiazepine (BZD) for the symptomatic management of patients in or at risk of severe alcohol withdrawal syndrome (AWS).

Objective

The objective of this study was to assess the safety and efficacy of a PB loading dose in addition to symptom-triggered BZD treatment for patients in or at risk of severe AWS.

Methods

Between January 2024 and May 2025, patients treated for AWS were screened for inclusion. Criteria for inclusion were age of at least 18 years old, a Prediction of Alcohol Withdrawal Severity Scale (PAWSS) score of 4 or higher, and a record of receiving treatment for AWS. Patients were excluded from the study if they were directly admitted to the intensive care unit (ICU) or psychiatric service, transferred to the ICU within 12 hours of admission, or with a length of stay less than 24 hours. The primary endpoint was the difference in cumulative BZD requirements. Secondary endpoints included the need for adjunct therapies, incidence of adverse events, and escalation of care.

Results

The final analysis included 75 patients in the BZD group and 63 patients in the PB group. There was a statistically significant decrease in the cumulative BZD utilization in the PB loading group. Patients who exclusively received BZD therapy for AWS used an average of 148 mg of diazepam equivalents versus 112 mg in the PB group ( P = 0.002). The PB group was also associated with a statistically significant reduction in the incidence of hypotension, respiratory depression, and the need for adjunct therapies. Conclusions and relevance: The addition of a weight-based PB loading dose showed a significant reduction in BZD utilization for patients in or at risk of severe AWS and was associated with fewer adverse events. Application of this information may aid in enhancing treatment for patients in or at risk of severe AWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenobarbitalBenzodiazepinesSubstance Withdrawal SyndromeHypnotics and SedativesHumansMaleFemaleMiddle AgedAdultDrug Therapy, CombinationDose-Response Relationship, Drug

Stichwörter der Autor:innen

alcohol withdrawal syndromebenzodiazepinephenobarbital

Substanzen

PhenobarbitalBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Pharmacy, Frederick Health Hospital, Frederick, MD, USA.
  • Intensive Care Unit, Frederick Health Hospital, Frederick, MD, USA.

ORCID-Profile: Taylor Le

Zitieren

APA

Le, T., Staas, S., Firmin, R., Dwyer, J., Bushell, T., Mishra, C., & Smoot, T. (2026). Evaluation of Phenobarbital Loading Dose in Reducing Cumulative Benzodiazepine Utilization in Patients With Alcohol Withdrawal Syndrome. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251383490

Vancouver

Le T, Staas S, Firmin R, Dwyer J, Bushell T, Mishra C, et al. Evaluation of Phenobarbital Loading Dose in Reducing Cumulative Benzodiazepine Utilization in Patients With Alcohol Withdrawal Syndrome. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251383490

BibTeX
@article{Le2026,
  author = {Le, Taylor and Staas, Sabrina and Firmin, Robyn and Dwyer, Jennifer and Bushell, Thomas and Mishra, Chaitanya and Smoot, Thomas},
  title = {Evaluation of Phenobarbital Loading Dose in Reducing Cumulative Benzodiazepine Utilization in Patients With Alcohol Withdrawal Syndrome},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280251383490}
}
Kostenlos starten →